There are several different factors that come into play when deciding which treatment pathway is best suited for your specific situation. Please keep reading to learn more.
T-cell lymphomas and leukemias are diseases that are responsive to traditional chemotherapy – in addition to the newer targeted agents that continue to improve the outcomes of patients with these diseases.
For your convenience we've provided a list of open, actively recruiting clinical trials. To review your treatment options and check your eligibility, please speak with your medical provider.